Finland· FI-REL-REL21332
Equinasil Comp
A quinapril und diuretika product containing quinapril hydrochloride + hydrochlorothiazide, registered in Finland by Medis Danmark A/S c/o Deloitte. 4W-FI. Larsen. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Quinapril und diuretika is registered in 5 of 19 countries.
Countries holding a registration under ATC C09BA06 (quinapril und diuretika), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Quinapril und diuretika · ATC C09BA06
5 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Italyprice
- Netherlands
The record
At a glance
Fimea (Finland)- Active substance
- Quinapril hydrochloride + Hydrochlorothiazide
- Manufacturer
- Medis Danmark A/S c/o Deloitte. 4W-FI. Larsen
- Country
- Finland (FI)
- ATC code
- C09BA06
- ATC class
- Quinapril und Diuretika
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
67 interactions on record for quinapril und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quinapril und diuretika · interactions on record
67 records
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Quinapril und diuretika in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesQuinapril and HydrochlorothiazideChartwell RX, LLC
- United KingdomAccuretic 10mg/12.5mg tabletsSigma Pharmaceuticals Plc
- CanadaAURO-QUINAPRIL HCTZAURO PHARMA INC
- ItalyQUINAPRIL E IDROCLOROTIAZIDE MYLAN GENERICSMYLAN S.P.A.
- FranceACUILIX 20 mg/12,5 mg, comprimé pelliculé sécablePFIZER HOLDING FRANCE
- SpainBICETIL 20 mg / 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULALaboratorios Menarini S.A.
- GermanyQuinaplusStadapharm Gmbh
- SwedenKinoprilam comp 10 mg/12,5 mg Filmdragerad tablettSTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Quinaplus, Quinapril/Hydrochlorothiazid Aurobindo
- Spain · Lidaltrin-Diu
- France · Acuilix, Quinapril Hydrochlorothiazide Eg
- Italy · Quinapril E Idroclorotiazide Mylan Generics, Quinapril Idroclorotiazide Aurobindo
- Netherlands · Quinapril/Hct Cf
- Sweden · Kinoprilam Comp
- Slovakia · Stadapress
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b16f4f93-eb70-43ae-aaad-450a10f2b3a6 GET /v1/drugs/b16f4f93-eb70-43ae-aaad-450a10f2b3a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "ED",
"strength": "10 mg / 12.5 mg",
"atc_label": "kinapriili ja diureetit",
"ma_number": "19388",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL21332",
"authorised_at": "2005-01-17"
}See everything about quinapril und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.